Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             135 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis Lampugnani, Maria Grazia
 2007
 120 S2 p. S1-S6
6 p.
 artikel
2 Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model Hobbs, Jennifer E.
 2007
 120 S2 p. S13-S21
9 p.
 artikel
3 Approaches to risk-stratifying cancer patients for venous thromboembolism Khorana, Alok A.
 2007
 120 S2 p. S41-S50
10 p.
 artikel
4 Author index, 4th International Conference on Thrombosis and Hemostasis Issues in Cancer, October 26–28, 2007, Bergamo, Italy 2007
 120 S2 p. S179-S182
4 p.
 artikel
5 Bleeding and thrombosis in acute leukemia: What does the future of therapy look like? Rickles, Frederick R.
 2007
 120 S2 p. S99-S106
8 p.
 artikel
6 Cancer, thrombosis and heparin-induced thrombocytopenia Prandoni, Paolo
 2007
 120 S2 p. S137-S140
4 p.
 artikel
7 Growth regulated oncogene is pivotal in thrombin-induced angiogenesis Karpatkin, Simon
 2007
 120 S2 p. S71-S74
4 p.
 artikel
8 Hemorrhagic and thrombotic complications in bone marrow transplant recipients Nadir, Yona
 2007
 120 S2 p. S92-S98
7 p.
 artikel
9 Heparanase, heparin and the coagulation system in cancer progression Vlodavsky, Israel
 2007
 120 S2 p. S112-S120
9 p.
 artikel
10 Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects Stevenson, Jennifer L.
 2007
 120 S2 p. S107-S111
5 p.
 artikel
11 Lessons learned from cancer/VTE Registries: Report from RIETE Monreal, Manuel
 2007
 120 S2 p. S62-S63
2 p.
 artikel
12 Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis Palumbo, Joseph S.
 2007
 120 S2 p. S22-S28
7 p.
 artikel
13 OC-10 Anticoagulant effects after termination of therapy using once weekly subcutaneous injections of idraparinux in patients with acute venous thromboembolism Harenberg, J.
 2007
 120 S2 p. S144-
1 p.
 artikel
14 OC-03 A population-based cohort study of the incidence of venous thromboembolism in Danish cancer patients compared to the general population Cronin-Fenton, D.P.
 2007
 120 S2 p. S142-
1 p.
 artikel
15 OC-08 Effects of low-molecular-weight heparins on metastatic tumor development in animal models Klerk, C.P.W.
 2007
 120 S2 p. S143-S144
2 p.
 artikel
16 OC-07 Enhanced thrombotic activity in association with increased circulating tissue factor activity in a mouse model of lymphoma Taubman, M.B.
 2007
 120 S2 p. S143-
1 p.
 artikel
17 OC-02 Inflammatory-like activation of endothelial cells in hematogenous metastasis L¨aubli, H.
 2007
 120 S2 p. S141-
1 p.
 artikel
18 OC-01 Inhibition of anti-angiogenesis cardiovascular events and chemotherapy cardiotoxicity by angioprevention agents Albini, A.
 2007
 120 S2 p. S141-
1 p.
 artikel
19 OC-05 Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in human melanoma Silini, A.
 2007
 120 S2 p. S142-S143
2 p.
 artikel
20 OC-04 The role of platelet microparticles in angiogenesis and tumor biology Brill, A.
 2007
 120 S2 p. S142-
1 p.
 artikel
21 OC-06 Tissue factor-bearing microparticles are associated with an increased risk of venous thromboembolic events in cancer patients Zwicker, J.I.
 2007
 120 S2 p. S143-
1 p.
 artikel
22 OC-09 Usual care compared with long-term low-molecular-weight heparin in patients with cancer and proximal venous thrombosis Hull, R.D.
 2007
 120 S2 p. S144-
1 p.
 artikel
23 PO-66 Abnormal fibrin formation secondary to multiple myeloma Dyr, J.E.
 2007
 120 S2 p. S166-
1 p.
 artikel
24 PO-26 Activated factor VII–Antithrombin complex (FVIIa-AT) in patients with acute promyelocytic leukemia (APL) Balducci, D.
 2007
 120 S2 p. S153-
1 p.
 artikel
25 PO-69 Activated protein C (APC) resistance in hematological malignancies Negaard, H.F.S.
 2007
 120 S2 p. S167-
1 p.
 artikel
26 PO-36 A high platelet count independently predicts venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Simanek, R.
 2007
 120 S2 p. S156-
1 p.
 artikel
27 PO-76 Alterations in oestradiol-mediated oestrogen receptor alpha activity in breast cancer cells in response to exogenous tissue factor Collier, M.E.W.
 2007
 120 S2 p. S169-
1 p.
 artikel
28 PO-57 Antineoplastic role of enoxaparin in neuroectodermal tumor cell lines Crescenzio, N.
 2007
 120 S2 p. S163-
1 p.
 artikel
29 PO-20 Antiphospholipid antibodies spectrum in genital cancer patients with thrombosis in past history Makatsaria, A.
 2007
 120 S2 p. S151-
1 p.
 artikel
30 PO-78 An unusual case of pulmonary thromboembolism Giusto, L.
 2007
 120 S2 p. S170-
1 p.
 artikel
31 PO-72 A rare case of portal vein thrombosis complicating juvenile idiopathic myelofibrosis with intrahepatic haematopoiesis Pulini, S.
 2007
 120 S2 p. S168-
1 p.
 artikel
32 PO-19 Are quantitative D-dimer levels only useful in the diagnosis of venous thrombosis? Predictive role of quantitative D-dimer levels in patients with venous thrombosis Paneesha, S.
 2007
 120 S2 p. S151-
1 p.
 artikel
33 PO-22 Assessment of thrombotic risk in cancer patients: proposal for a scoring system. A monocentric study Giordano, G.
 2007
 120 S2 p. S152-
1 p.
 artikel
34 PO-81 Association between tumour tissue factor expression and codon 12 K-ras mutation in non-small cell lung cancer Regina, S.
 2007
 120 S2 p. S170-S171
2 p.
 artikel
35 PO-48 Asymptomatic inferior vena cava and iliac vein thrombosis in cancer patients: a difficult diagnosis and treatment management Casals, F.J.
 2007
 120 S2 p. S160-
1 p.
 artikel
36 PO-03 bFGF, IL-6, TNF-α and VEGF serum levels in newly diagnosed multiple myeloma patients treated with thalidomide, dexamethasone and autologous transplantation Cellini, C.
 2007
 120 S2 p. S145-S146
2 p.
 artikel
37 PO-61 Cancer and symptomatic venous thromboembolism rates: VERITY Registry findings Rose, P.
 2007
 120 S2 p. S164-
1 p.
 artikel
38 PO-29 Cancer procoagulant expression and fibrin clot formation in the tumor cells environment in vitro Kaplinska, K.
 2007
 120 S2 p. S154-
1 p.
 artikel
39 PO-97 Central venous lines related venous thrombosis (CVL-VT) in children with acute lymphoblastic leukemia (ALL): outcome and impact on survival Saracco, P.
 2007
 120 S2 p. S175-S176
2 p.
 artikel
40 PO-06 Characterization of TFPI deficiency in vascular cells Sletten, M.
 2007
 120 S2 p. S146-S147
2 p.
 artikel
41 PO-56 Chemoanticoagulation versus chemotherapy in advanced pancreatic cancer (APC): results of the interim analysis of the FRAGEM trial Maraveyas, A.
 2007
 120 S2 p. S163-
1 p.
 artikel
42 PO-01 Cisplatin induces thrombin generation via formation of procoagulant endothelial microparticles in vitro Lechner, D.
 2007
 120 S2 p. S145-
1 p.
 artikel
43 PO-90 Clinical characteristics of cancer associated acute venous thromboembolism: findings from the MASTER Registry Imberti, D.
 2007
 120 S2 p. S173-S174
2 p.
 artikel
44 PO-21 Clinical significance of revealing combination of genetic forms of thrombophilia and APA in cancer patients with recurrent thrombosis Volkova, V.
 2007
 120 S2 p. S151-S152
2 p.
 artikel
45 PO-93 Combined use of clinical pretest probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients Stender, M.T.
 2007
 120 S2 p. S174-S175
2 p.
 artikel
46 PO-63 Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study Seeholzer, N.
 2007
 120 S2 p. S165-
1 p.
 artikel
47 PO-23 Correlation of thrombosis and prothrombotic markers with survival in lung adenocarcinoma patients: a prospective study de Meis, E.
 2007
 120 S2 p. S152-
1 p.
 artikel
48 PO-08 Defibrotide, an anti-thrombotic drug, prevents angiogenesis in vitro and in vivo Eissner, G.
 2007
 120 S2 p. S147-
1 p.
 artikel
49 PO-71 Detection of procoagulant phospholipids in plasma from patients with thyroid cancer Woodhams, B.
 2007
 120 S2 p. S167-
1 p.
 artikel
50 PO-05 Determinants of homocysteine levels in colorectal and breast cancer patients Ferroni, P.
 2007
 120 S2 p. S146-
1 p.
 artikel
51 PO-14 Diagnostic characteristics in patients with clinically suspected deep venous thrombosis with and without malignancy van Sluis, G.L.
 2007
 120 S2 p. S149-
1 p.
 artikel
52 PO-83 Differential procoagulant phenotype of pancreatic and breast cancer cells related to different tissue factor activity Gerotziafas, G.T.
 2007
 120 S2 p. S171-
1 p.
 artikel
53 PO-45 Do all patients with venous thrombosis require screening for malignancy? A predictive model to identify patients with VTE at minimal risk of malignancy Paneesha, S.
 2007
 120 S2 p. S159-
1 p.
 artikel
54 PO-07 Dual implication of endothelial protein C receptor (EPCR) in cancer homoeostasis Ducros, E.
 2007
 120 S2 p. S147-
1 p.
 artikel
55 PO-34 Effect of thrombin and platelets on ovarian cancer cell invasion Ornstein, D.L.
 2007
 120 S2 p. S155-S156
2 p.
 artikel
56 PO-24 Elevated levels of Factor VIII in patients with multiple myeloma treated with thalidomide Cosmi, B.
 2007
 120 S2 p. S152-S153
2 p.
 artikel
57 PO-33 Elevated levels of platelet and endothelial microparticles in patients with essential thrombocythaemia Trappenburg, M.
 2007
 120 S2 p. S155-
1 p.
 artikel
58 PO-82 Endogenous production of nitric oxide controls the activation state of cell surface tissue factor Liang, H.
 2007
 120 S2 p. S171-
1 p.
 artikel
59 PO-02 Endothelial protein C receptor in breast cancer cell lines Tagliavacca, L.
 2007
 120 S2 p. S145-
1 p.
 artikel
60 PO-103 Epidemiological study: causes of deaths in Ptolemaida City Makris, M.P.
 2007
 120 S2 p. S177-S178
2 p.
 artikel
61 PO-89 Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy Sayed-Ahmed, N.
 2007
 120 S2 p. S173-
1 p.
 artikel
62 PO-30 Expression analysis of a missense mutation in the protein C gene in cancer cell lines Tjeldhorn, L.
 2007
 120 S2 p. S154-
1 p.
 artikel
63 PO-09 Expression of alternatively spliced tissue factor in human endothelial cells: induction by inflammatory stimuli and modulation by heparins Brambilla, M.
 2007
 120 S2 p. S147-
1 p.
 artikel
64 PO-28 Expression of tissue factor (TF), tissue factor pathway inhibitor (TFPI), factor IX and factor X in breast cancer: comparison between primary tumor and metastatic lesions in regional lymph nodes Wojtukiewicz, M.Z.
 2007
 120 S2 p. S154-
1 p.
 artikel
65 PO-100 Factor V Leiden (FVL), prothrombin, MTHFR and PAI-1 polymorphisms and cancer risk in women; the Jerusalem Perinatal Study (JPS) Tiram, E.
 2007
 120 S2 p. S176-S177
2 p.
 artikel
66 PO-80 Functional endothelial protein C receptor detected on human malignant cells Ducros, E.
 2007
 120 S2 p. S170-
1 p.
 artikel
67 PO-16 Hemostatic activation, fibrinolysis, and angiogenesis prior to radical retropubic prostatectomy Tagawa, S.T.
 2007
 120 S2 p. S150-
1 p.
 artikel
68 PO-04 Heparanase induces TFPI expression and extracellular accumulation in endothelial and tumor cells Nadir, Y.
 2007
 120 S2 p. S146-
1 p.
 artikel
69 PO-52 Heparins inhibit lung cancer cells proliferation in vitro Carmazzi, Y.
 2007
 120 S2 p. S161-
1 p.
 artikel
70 PO-54 High dose warfarin inhibits cell proliferation and induces apoptosis in leukaemia K562 and HL-60 cells Ulutin, T.
 2007
 120 S2 p. S162-
1 p.
 artikel
71 PO-94 Higher risk of death in patients with cervical cancer IIIB with venous thromboembolism in Rio de Janeiro, Brazil Renni, M.
 2007
 120 S2 p. S175-
1 p.
 artikel
72 PO-92 High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer Stender, M.T.
 2007
 120 S2 p. S174-
1 p.
 artikel
73 PO-74 Hypercoagulability in multiple myeloma Petropoulou, A.D.
 2007
 120 S2 p. S168-S169
2 p.
 artikel
74 PO-67 Hypercoagulable parameters as predictors of prognosis in patients with advanced non-small cell lung carcinoma Sarig, G.
 2007
 120 S2 p. S166-
1 p.
 artikel
75 PO-37 Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells Filippi, I.
 2007
 120 S2 p. S156-
1 p.
 artikel
76 PO-11 Immunity, thrombosis and survival in lung adenocarcinoma patients: a prospective study de Meis, E.
 2007
 120 S2 p. S148-
1 p.
 artikel
77 PO-101 Incidence, clinical-laboratory features, management and follow-up of acquired von Willebrand syndrome and other acquired defects of hemostasis in a cohort of 135 patients with chronic lymphoproliferative disorders Pugliano, M.T.
 2007
 120 S2 p. S177-
1 p.
 artikel
78 PO-44 Incidence of venous thromboembolism in patients undergoing thoracotomy for cancer Dentali, F.
 2007
 120 S2 p. S158-S159
2 p.
 artikel
79 PO-102 Incidental, asymptomatic, unsuspected pulmonary embolism in cancer patients: case reports Silingardi, M.
 2007
 120 S2 p. S177-
1 p.
 artikel
80 PO-38 Increased expression of tissue factor, PAR-1 and interleukin-8 in esophageal cancer patients Ribeiro, F.
 2007
 120 S2 p. S157-
1 p.
 artikel
81 PO-64 Induction of tissue factor and loss of thrombomodulin activities upon inflammatory stimulation in vivo Spronk, H.M.H.
 2007
 120 S2 p. S165-
1 p.
 artikel
82 PO-86 Integrin alpha(v)beta(3) and osteopontin promote hematogenous metastasis of osteosarcoma cells to the lung Hassenpflug, W.A.
 2007
 120 S2 p. S172-
1 p.
 artikel
83 PO-10 In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration Festuccia, C.
 2007
 120 S2 p. S148-
1 p.
 artikel
84 PO-65 Is abnormal coagulation a possible prognostic factor for efficacy of immunotherapy in metastatic renal cell carcinoma patients? Madzhuga, A.
 2007
 120 S2 p. S165-S166
2 p.
 artikel
85 PO-84 Leptin enhances tissue factor expression by the human breast cancer cell line MCF7 Napoleone, E.
 2007
 120 S2 p. S171-S172
2 p.
 artikel
86 PO-88 Localization of coagulation proteins in malignant colon tissue Otten, J.M.M.B.
 2007
 120 S2 p. S173-
1 p.
 artikel
87 PO-58 Low-molecular weight heparin antagonizes the CXCL12-driven migration of chronic lymphocytic leukemia B cells Vianello, F.
 2007
 120 S2 p. S163-S164
2 p.
 artikel
88 PO-47 Low molecular weight heparin (LMWH) administration in patients suffering from pulmonary embolism and brain metastases (mts): a report of two cases Vitale, F.V.
 2007
 120 S2 p. S160-
1 p.
 artikel
89 PO-13 Low-molecular weight heparin (LMWH) bemiparin and ultra-low-MWH RO-14 inhibit lung, breast and leukemia cancer cell-induced endothelial angiogenesis Vignoli, A.
 2007
 120 S2 p. S149-
1 p.
 artikel
90 PO-42 Low-molecular-weight heparin (LMWH) in acute leukaemia (AL) patients with severe thrombocytopenia and concomitant venous or arterial thrombosis Cedrone, M.
 2007
 120 S2 p. S158-
1 p.
 artikel
91 PO-43 Low molecular weight heparin (LMWH) in central venous catheter antithrombotic prophylaxis: meta-analysis of randomized clinical trials Tassinari, D.
 2007
 120 S2 p. S158-
1 p.
 artikel
92 PO-59 Low molecular weight heparin (LMWH) versus best supportive care in cancer patients. A meta-analysis of randomized clinical trials Laporte, S.
 2007
 120 S2 p. S164-
1 p.
 artikel
93 PO-85 Malignant transformation in melanocytes increases the production of procoagulant microvesicles Lima, L.G.
 2007
 120 S2 p. S172-
1 p.
 artikel
94 PO-50 Management practices of Connecticut physicians for treatment of cancer patients with venous thrombosis Dhami, R.
 2007
 120 S2 p. S161-
1 p.
 artikel
95 PO-60 Meta-analysis of randomised comparisons between the effects of warfarin and low molecular weight heparin in thromboprophylaxis and mortality in cancer patients Young, A.M.
 2007
 120 S2 p. S164-
1 p.
 artikel
96 PO-41 Multidetector CT of deep venous thrombosis in a gynecological oncologic patient: a case report Renni, M.
 2007
 120 S2 p. S157-S158
2 p.
 artikel
97 PO-104 Non Hodgkin lymphoma (NHL) and deep venous thrombosis: a dangerous liaison still unexplored Giordano, G.
 2007
 120 S2 p. S178-
1 p.
 artikel
98 PO-99 Outcomes in cancer patients with unsuspected pulmonary emboli found on staging CT scans O'Connell, C.
 2007
 120 S2 p. S176-
1 p.
 artikel
99 PO-17 Patterns of procoagulant and immunoinflammatory response following chemoradiotherapy and surgery for oesophageal cancer Byrne, M.
 2007
 120 S2 p. S150-
1 p.
 artikel
100 PO-53 Phase II study of low molecular weight heparin (LMWH) in combination with immunotherapy in metastatic renal cell carcinoma patients Tsimafeyeu, I.
 2007
 120 S2 p. S162-
1 p.
 artikel
101 PO-32 Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer Palmirotta, R.
 2007
 120 S2 p. S155-
1 p.
 artikel
102 PO-25 Predictive value for VTE of hemostatic markers in patients with multiple myeloma receiving thalidomide Falanga, A.
 2007
 120 S2 p. S153-
1 p.
 artikel
103 PO-73 Prevalence of cancer and congenital thrombophilia in 435 patients with acute venous thromboembolism (VTE) Achkar, A.
 2007
 120 S2 p. S168-
1 p.
 artikel
104 PO-70 Prevalence of hereditary and acquired thrombophilia in patients with gynaecologic malignancy and women with breast cancer Dilenge, S.
 2007
 120 S2 p. S167-
1 p.
 artikel
105 PO-49 Preventing surgical blood loss in cancer patients using fibrin monomer and F.XIII - proof of concept with a double blind randomized trial Korte, W.
 2007
 120 S2 p. S160-S161
2 p.
 artikel
106 PO-62 Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris Carneiro-Lobo, T.C.
 2007
 120 S2 p. S165-
1 p.
 artikel
107 PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results Perry, J.
 2007
 120 S2 p. S157-
1 p.
 artikel
108 PO-18 Pulmonary tumor emboli: often reviewed and clinically forgotten Patton, W.
 2007
 120 S2 p. S150-S151
2 p.
 artikel
109 PO-27 Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis Heptinstall, S.
 2007
 120 S2 p. S153-S154
2 p.
 artikel
110 PO-79 Reduction of serum tissue factor levels (BB-TF) in advanced pancreatic cancer (APC) patients treated with dalteparin correlates with reduction of chemotactic properties of patients' sera: results from the FRAGEM translational study Maraveyas, A.
 2007
 120 S2 p. S170-
1 p.
 artikel
111 PO-35 Role of platelet and tumour cell receptors in breast adenocarcinoma MDA-MB-231 cell adhesion to the subendothelium in whole blood and under flow conditions Djaafri, I.
 2007
 120 S2 p. S156-
1 p.
 artikel
112 PO-15 Should common inherited thrombophilic abnormalities be tested in cancer patients with central venous catheter? Dentali, F.
 2007
 120 S2 p. S149-S150
2 p.
 artikel
113 PO-68 TEG: a potential marker of thromboembolic risk in cancer patients? Bochsen, L.
 2007
 120 S2 p. S166-S167
2 p.
 artikel
114 PO-96 The incidence of cancer after an idiopathic thrombophlebitis – a historic follow-up study in primary care v. Doormaal, F.F.
 2007
 120 S2 p. S175-
1 p.
 artikel
115 PO-77 The influence of tissue factor on the methylation of oestrogen receptor alpha gene during breast cancer Collier, M.E.W.
 2007
 120 S2 p. S169-S170
2 p.
 artikel
116 PO-39 The management of venous thromboembolism in patients with advanced metastatic cancer: experiences of a palliative care service Noble, S.I.R.
 2007
 120 S2 p. S157-
1 p.
 artikel
117 PO-55 The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer Siragusa, S.
 2007
 120 S2 p. S162-S163
2 p.
 artikel
118 PO-12 The prothrombotic and proangiogenic potential of microvascular endothelial cells induced by tumor cells is reduced by the low molecular weight heparin (LMWH) dalteparin Vignoli, A.
 2007
 120 S2 p. S148-S149
2 p.
 artikel
119 PO-31 Thrombin cleaves in vitro FGF-2 and modulates its biological activity Totta, P.
 2007
 120 S2 p. S155-
1 p.
 artikel
120 PO-75 Thrombin generation in patients with essential thrombocythemia (ET) Marchetti, M.
 2007
 120 S2 p. S169-
1 p.
 artikel
121 PO-51 Thrombosis and central venous catheters in cancer patients Young, A.M.
 2007
 120 S2 p. S161-
1 p.
 artikel
122 PO-87 Tissue factor inhibition in human cancer and tumor-associated host cells by paclitaxel Napoleone, E.
 2007
 120 S2 p. S172-
1 p.
 artikel
123 PO-98 Venous thromboembolism (VTE) as first sign of occult malignancy is associated with increased risk of recurrent VTE Brækkan, S.
 2007
 120 S2 p. S176-
1 p.
 artikel
124 PO-95 Venous thromboembolism (VTE) is associated with recurrent cancer in patients with initially non-metastatic breast, lung, and colon cancer Wun, T.
 2007
 120 S2 p. S175-
1 p.
 artikel
125 PO-91 Venous thromboses in children treated for acute lymphoblastic leukaemia (FRALLE 2000) Pautard, B.
 2007
 120 S2 p. S174-
1 p.
 artikel
126 PO-46 Venous thrombosis (VTE) shortens the survival in patients with malignancy Paneesha, S.
 2007
 120 S2 p. S159-
1 p.
 artikel
127 Prevention of VTE in multiple myeloma patients Zamagni, Elena
 2007
 120 S2 p. S133-S136
4 p.
 artikel
128 Protease signaling in tumor progression Camerer, Eric
 2007
 120 S2 p. S75-S81
7 p.
 artikel
129 Role of von Willebrand factor in tumor metastasis Terraube, Virginie
 2007
 120 S2 p. S64-S70
7 p.
 artikel
130 Targeting patients for anticoagulant prophylaxis trials in patients with cancer: Who is at highest risk? White, Richard H.
 2007
 120 S2 p. S29-S40
12 p.
 artikel
131 The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer Lee, Agnes Y.Y.
 2007
 120 S2 p. S121-S127
7 p.
 artikel
132 The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression Milsom, Chloe
 2007
 120 S2 p. S82-S91
10 p.
 artikel
133 Thrombophilia and risk of venous thrombosis in patients with cancer Decousus, Hervé
 2007
 120 S2 p. S51-S61
11 p.
 artikel
134 Thromboprophylaxis during chemotherapy after advanced cancer Agnelli, Giancarlo
 2007
 120 S2 p. S128-S132
5 p.
 artikel
135 Tissue factor and PAR signaling in tumor progression Ruf, Wolfram
 2007
 120 S2 p. S7-S12
6 p.
 artikel
                             135 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland